drugset / Trial / NCT06974929
A Clinical Study of HRS-6209 Combined With Other Treatment Regimens in Patients With Breast Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This is a study to evaluate the safety, tolerability, and pharmacokinetic characteristics of HRS-6209 combined with other treatment regimens in breast cancer patients, and preliminarily observe its anti-tumor efficacy.
Timeline
- Start
- 2025-05-22
- Primary completion
- 2026-12
- Completion
- 2026-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS-2189 | Unknown | — | — |
| Subject | HRS-6209 | Small molecule | — | Oral |
| Background | Letrozole | Other / unclassified | — | Oral |